MetLife Investment Management’s Meredith Corporation MDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,929
Closed -$776K 2600
2021
Q3
$776K Sell
13,929
-2,330
-14% -$102K 0.01% 1264
2021
Q2
$706K Hold
16,259
0.01% 1368
2021
Q1
$484K Buy
16,259
+4,026
+33% +$106K ﹤0.01% 1544
2020
Q4
$235K Sell
12,233
-5,598
-31% -$90.9K ﹤0.01% 1897
2020
Q3
$234K Hold
17,831
﹤0.01% 1770
2020
Q2
$259K Sell
17,831
-23,074
-56% -$336K ﹤0.01% 1749
2020
Q1
$500K Hold
40,905
0.01% 1218
2019
Q4
$1.33M Sell
40,905
-231
-0.6% -$8.22K 0.01% 960
2019
Q3
$1.51M Sell
41,136
-434
-1% -$20.2K 0.02% 891
2019
Q2
$2.29M Buy
41,570
+611
+1% +$34.2K 0.02% 752
2019
Q1
$2.26M Buy
40,959
+53
+0.1% +$2.94K 0.02% 768
2018
Q4
$2.12M Sell
40,906
-1,744
-4% -$94.6K 0.03% 738
2018
Q3
$2.18M Sell
42,650
-685
-2% -$35.8K 0.02% 824
2018
Q2
$2.21M Buy
43,335
+260
+0.6% +$13.3K 0.03% 762
2018
Q1
$2.32M Sell
43,075
-299
-0.7% -$17.8K 0.03% 724
2017
Q4
$2.87M Buy
+43,374
New +$2.62M 0.03% 660

Other funds holding MDP

MetLife Investment Management's MDP Position: Q4 2021 in Review

MetLife Investment Management sold out of Meredith Corporation (MDP) in Q4 2021, closing a stake of 13,929 shares — an estimated $776K sold.

MetLife Investment Management first reported a position in MDP in Q4 2017 and held it in 16 quarters. The position peaked at $2.87M in Q4 2017. 1 fund tracked by Wall St. Rank holds MDP as of Q4 2021.

  • MetLife Investment Management reported no remaining Meredith Corporation position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 13,929 Meredith Corporation shares in Q4 2021, an estimated $776K.
  • MetLife Investment Management first reported a position in Meredith Corporation in Q4 2017 and held it in 16 quarters.
  • MetLife Investment Management's Meredith Corporation position peaked at $2.87M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Meredith Corporation as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.